Cytovance Biologics Expands GMP Warehouse and Manufacturing Operations - - BioPharm International

ADVERTISEMENT

Cytovance Biologics Expands GMP Warehouse and Manufacturing Operations



Cytovance Biologics, a full-service contract manufacturer of mammalian and microbial biologics, continues to work on the expansion of a manufacturing operations and GMP warehousing facility. The multi-million dollar capital investment project is expected to be completed by June 2014.
 
Cytovance selected a construction site two miles north of its current campus in Oklahoma.  The new facility, located at 3500 N. Santa Fe, will house 20,000 ft2 of climate controlled and monitored GMP warehouse space and 10,000 ft2 of space for existing and future manufacturing operations. Initially, this cleanroom space will be used for weighing and dispensing activities.
 
“Our new GMP warehouse will support incoming and outgoing supply-chain activities and provide full segregation between incoming, quarantine, and released materials,” explained Don Wuchterl, senior vice-president of manufacturing operations in a press release.

Source: Cytovance Biologics

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines

Click here